Altimmune, Inc. (NASDAQ:ALT) is one of the best high-return penny stocks to buy right now. On February 13, Titan Partners initiated coverage of Altimmune, Inc. (NASDAQ:ALT) with a Buy rating and a $7 ...

“Bad,” or LDL, cholesterol is a major risk factor for heart disease and most people are screened for it as part of their yearly physicals. There’s another marker in the blood that may be a better ...

Beyond Meat has made the surprise announcement that the US plant-based meat group has developed a range of drinks. The Beyond Burger business, one of the major names in meat-free, is test-launching a ...

If it feels like everyone is getting the flu, you're not imagining it. This is shaping up to be another severe flu season. That's why it's important to take advantage of every tool we have to keep the ...

Altimmune (ALT) recently released pemvidutide's 48-week topline results from their IMPACT Phase IIb trial, which revealed the drug's ability to continue improvement for several non-invasive fibrosis ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...

Pink hair, smoky eyes and barely-there brows are just some of the ways alt style is popping back into the mainstream. Once a thing of the 90s and 2010s, alt aesthetics are making a comeback, but this ...

Crypto majors bitcoin BTC $72,397.54, ether (ETH), xrp (XRP) and solana (SOL) consolidated over the past 24 hours following a volatile week that saw the broader market fall to the lowest levels in ...

All right. Good morning, everyone, to Jefferies' London Healthcare Conference 2025. My name is Roger Song, one of the senior analyst covering SMID-cap biotech in the U.S. It is my great pleasure to ...

The crypto market is weary after relentless waves of sell pressure on Tuesday. Several assets have now settled as they begin to establish levels of support, although if the U.S. dollar continues to ...

Joe Alt injured his ankle in Sunday's win over the Tennessee Titans. Denny Simmons / The Tennessean / Imagn Images EL SEGUNDO, Calif. — Los Angeles Chargers left tackle Joe Alt will undergo ...

The Chargers received news they were hoping to avoid on Monday, Left tackle Joe Alt will be out for the remainder of the 2025 season because of a high ankle sprain. He will undergo season-ending ankle ...